MENLO PARK, Calif., Sept. 4, 2019 /PRNewswire/ -- Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced the closing of $31 million in Series D Preferred Stock financing led by KCK Group, a leading investor in high

NEW YORK, Sept. 4, 2019 /PRNewswire/ -- Research Foundation to Cure AIDS (RFTCA) has obtained a worldwide license to biotechnology known as Chromovert® Technology, to research, develop and commercialize a cure for HIV/AIDS. This is the first and only case of an IRS Code § 501(c)3 not-for-profit organizati

SAN FRANCISCO, Sept. 4, 2019 /PRNewswire/ -- Tivic Health™ Systems Inc., a commercial phase bioelectronic company, will be exhibiting ClearUP® Sinus Pain Relief,

SALEM, N.H., Sept. 4, 2019 /PRNewswire/ -- Summit Diagnostics, the leader in innovative testing, now offers a new Validity Screen which now proves that the specimens being tested are real, unadulterated and not replaced with synthetics.  The US Drug Enforcement Agency (DEA) states that as much as 10 percent of all drug test samples have been adulterated, swit

DENVER, Sept. 4, 2019 /PRNewswire/ -- SCB Global Healthcare Services, LLC, a Denver based healthcare services holding company founded by Warren Olsen and Russ Matthews today announced that it has acquired the Gallus Detox Centers, a provider of customized inpatient medical deto

NEW YORK, Sept. 4, 2019 /PRNewswire/ -- Capital Rx (https://cap-rx.com), a next generation pharmacy benefits manager, announced today the launch of its Clearinghouse Model,

TORONTO, Sept. 4, 2019 /PRNewswire/ -- The Personal Trainer Development Center, the premier source of information and education for fitness professionals,

NEW YORK, Sept. 4, 2019 /PRNewswire/ -- The Mesothelioma Compensation Center says, "We are the best branded advocate in the nation for power or energy workers wit

CAMBRIDGE, Mass., Sept. 4, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the initiation of two clinical trials for IPI-549, a first-in

LAGUNA HILLS, Calif., Sept. 4, 2019 /PRNewswire/ -- Sonendo®, Inc., the developer of  the GentleWave® System, a breakthrough technology for the de